Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$0.9 - $1.51 $952 - $1,597
1,058 New
1,058 $0
Q3 2022

Oct 27, 2022

BUY
$1.06 - $2.41 $15,835 - $36,002
14,939 Added 1345.86%
16,049 $18,000
Q2 2022

Aug 01, 2022

SELL
$1.33 - $2.28 $12,458 - $21,356
-9,367 Reduced 89.41%
1,110 $2,000
Q1 2022

May 11, 2022

BUY
$1.73 - $4.06 $10,428 - $24,473
6,028 Added 135.49%
10,477 $22,000
Q4 2021

Feb 11, 2022

SELL
$3.5 - $5.68 $4,480 - $7,270
-1,280 Reduced 22.34%
4,449 $17,000
Q3 2021

Nov 10, 2021

BUY
$3.44 - $6.37 $15,789 - $29,238
4,590 Added 402.99%
5,729 $29,000
Q2 2021

Aug 05, 2021

SELL
$3.86 - $5.78 $725 - $1,086
-188 Reduced 14.17%
1,139 $5,000
Q1 2021

Apr 28, 2021

SELL
$4.9 - $6.83 $534 - $744
-109 Reduced 7.59%
1,327 $7,000
Q4 2020

Feb 04, 2021

SELL
$4.0 - $9.2 $1,884 - $4,333
-471 Reduced 24.7%
1,436 $7,000
Q3 2020

Nov 10, 2020

BUY
$7.66 - $10.78 $4,205 - $5,918
549 Added 40.43%
1,907 $15,000
Q2 2020

Aug 07, 2020

SELL
$2.58 - $12.1 $1,586 - $7,441
-615 Reduced 31.17%
1,358 $14,000
Q1 2020

May 13, 2020

BUY
$1.2 - $4.52 $2,367 - $8,917
1,973 New
1,973 $5,000

Others Institutions Holding ADAP

About Adaptimmune Therapeutics PLC


  • Ticker ADAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 163,370,000
  • Market Cap $73.5M
  • Description
  • Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...
More about ADAP
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.